PHILIP VINCENT: Open Payments
NPI 1114243524 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 20 payments from 5 companies in 2025. Trend: 2023 $187 · 2024 $129 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $156 |
| Teva Pharmaceuticals USA, Inc. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: VRAYLAR, UZEDY, ABILIFY ASIMTUFII, COBENFY, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
